DNAJC19 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HeLa human cervical adenocarcinoma cell line, targeting the DNAJC19 gene encoding the mitochondrial Hsp40 co-chaperone. This loss-of-function model enables investigation of mitochondrial protein import, cardiolipin metabolism, and cristae architecture, with the polyclonal format preserving heterogeneity from CRISPR/Cas9-mediated gene disruptions, minimizing clonal selection artifacts.
The HeLa cell line, an immortalized epithelial model from cervical adenocarcinoma harboring HPV18 sequences, is widely employed in cancer biology and general cell research. Its rapid proliferation and adaptability to diverse culture conditions make it suitable for gene-editing workflows, and its well-characterized genetic background supports reliable generation of knockout models for mitochondrial studies.
DNAJC19 functions as a co-chaperone in the TIMM23 mitochondrial import complex, interacting with TIMM23, TIMM17, TIMM44, and PAM16 to facilitate precursor protein translocation across the inner membrane. Upstream regulators NRF1, PGC-1?? (PPARGC1A), and TFAM orchestrate mitochondrial biogenesis and stress adaptation, while downstream, DNAJC19 supports cardiolipin remodeling by promoting CRLS1 activity and maintaining mitochondrial membrane potential. It collaborates with mtHsp70, PHB2, and OPA1 to preserve cristae architecture and protein quality control, thereby linking import efficiency to the mitochondrial unfolded protein response (UPRmt).
In HeLa cells, which exhibit heightened metabolic activity and distorted mitochondrial dynamics typical of cancer, DNAJC19 knockout presents a valuable model to interrogate mitochondrial dysfunction. This system can recapitulate features of dilated cardiomyopathy with ataxia (DCMA) and broader mitochondrial pathologies, as loss of DNAJC19 impairs cardiolipin metabolism and protein import. Consequently, the model permits investigation of how defective mitochondrial import and lipid remodeling influence cellular bioenergetics, apoptosis susceptibility, and stress signaling in a cancerous milieu, offering insights into mitochondrial vulnerabilities that may be targeted therapeutically.
Typical assays include western blotting to verify DNAJC19 ablation, mitochondrial isolation coupled with in vitro import assays to probe TIMM23 function, and immunofluorescence to visualize cristae organization. Seahorse respirometry provides metabolic flux data, while co-immunoprecipitation reveals disrupted interactions with TIMM23, PHB2, or mtHsp70. Lipidomics detects shifts in cardiolipin species, and JC-1 staining assesses mitochondrial membrane potential; transcriptional responses to stress are monitored by RT-qPCR. These applications facilitate detailed study of mitochondrial protein import, cardiolipin metabolism, and quality control, as well as drug screening focused on mitochondrial targets. For technical support or ordering information, please contact Ascent Research.
